Plus Therapeutics, Inc.
PSTV
$0.7691
-$0.075-8.89%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.90M | -2.87M | -2.94M | -3.26M | -3.81M |
| Total Depreciation and Amortization | 103.00K | 232.00K | 233.00K | 155.00K | 65.00K |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 4.00K | 16.00K | 30.00K |
| Total Other Non-Cash Items | 216.00K | -882.00K | -1.05M | 178.00K | 258.00K |
| Change in Net Operating Assets | 2.37M | -156.00K | 2.61M | -1.60M | 1.58M |
| Cash from Operations | -1.21M | -3.68M | -1.15M | -4.51M | -1.88M |
| Capital Expenditure | -11.00K | -14.00K | -81.00K | -40.00K | -42.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 75.00K | 5.00K | -3.72M | -324.00K | -- |
| Cash from Investing | 64.00K | -9.00K | -3.80M | -364.00K | -42.00K |
| Total Debt Issued | 0.00 | 0.00 | 3.29M | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -3.59M | -402.00K | -402.00K |
| Issuance of Common Stock | 0.00 | 0.00 | 7.27M | -- | 147.00K |
| Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | -374.00K | -126.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -148.00K |
| Cash from Financing | 0.00 | 0.00 | 6.96M | -776.00K | -529.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.15M | -3.69M | 2.01M | -5.65M | -2.45M |